Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors

Effective treatments for androgen-independent prostate cancer (AIPCa) are lacking. To address this, emerging therapeutics such as proteasome inhibitors are currently undergoing clinical trials. Inositol hexakisphosphate (IP6) is an orally non-toxic phytochemical that exhibits antitumour activity aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Diallo, J-S, Betton, B, Parent, N, Péant, B, Lessard, L, Le Page, C, Bertrand, R, Mes-Masson, A-M, Saad, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584963/
https://www.ncbi.nlm.nih.gov/pubmed/18941459
http://dx.doi.org/10.1038/sj.bjc.6604730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584963/
https://www.ncbi.nlm.nih.gov/pubmed/18941459
http://dx.doi.org/10.1038/sj.bjc.6604730

Ejemplares similares